{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group ( POG ) P9605 ( standard risk ) and P9201 ( lesser risk ) acute lymphoblastic leukemia protocols ( ACCL0131 ) : a methotrexate consequence ?\n\nLet's think step by step."},
    {"role": "assistant", "content": "Sure! Here are the \"Disease\" entities identified in the paragraph:\n\n| Disease |\n| --- |\n| Neurocognitive late effects |\n| Neuroradiologic central nervous system late effects |\n| Acute lymphoblastic leukemia (ALL) |\n| Methotrexate consequence |\n\nNote that \"Neurocognitive late effects\" and \"Neuroradiologic central nervous system late effects\" are both mentioned as potential consequences of treatment with methotrexate, which is a chemotherapy drug used to treat ALL."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Of course! Here are the valid \"Disease\" entities identified in the paragraph:\n\n| Disease |\n| --- |\n| Acute lymphoblastic leukemia (ALL) |\n| Methotrexate consequence |\n\nI removed the following entities that do not clearly refer to \"Disease\":\n\n* \"Neurocognitive late effects\"\n* \"Neuroradiologic central nervous system late effects\""}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group ( POG ) P9605 ( standard risk ) and P9201 ( lesser risk ) acute lymphoblastic leukemia protocols ( ACCL0131 ) : a methotrexate consequence ?\n\nLet's think step by step."},
    {"role": "assistant", "content": "Sure! Here are the \"Chemical\" entities mentioned in the paragraph:\n\n| Chemical |\n| --- |\n| Methotrexate |\n\nThe entity \"Methotrexate\" is mentioned in the paragraph as a possible consequence of treatment on the Pediatric Oncology Group (POG) P9605 and P9201 acute lymphoblastic leukemia protocols (ACCL0131)."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Of course! Here are the valid \"Chemical\" entities mentioned in the paragraph:\n\n| Chemical |\n| --- |\n| Methotrexate |\n\nThe entity \"Methotrexate\" is mentioned in the paragraph as a possible consequence of treatment on the Pediatric Oncology Group (POG) P9605 and P9201 acute lymphoblastic leukemia protocols (ACCL0131)."}
  ]
}